Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine infusion for postherpetic neuralgia with fMRI mechanistic assessment
ChiCTR2200055710Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine in postherpetic neuralgia (PHN) (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Functional connectivity in resting-state fMRI and Activated cortical regions during task-based fMRI. Started Oct 2020; status: recruiting.
02
Drugs
lidocaine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on ChiCTR2200055710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055710.